Literature DB >> 28509123

Serum calcitriol levels in a patient with X-linked hypophosphatemia complicated by autosomal dominant polycystic kidney disease.

Satomi Kajita1, Takehisa Yamamoto2, Naoko Tsugawa3, Hirohumi Nakayama4, Takuo Kubota4, Toshimi Michigami5, Keiichi Ozono4.   

Abstract

Serum calcitriol [1,25(OH)2D] levels are low normal in the presence of hypophosphatemia in X-linked dominant hypophosphatemic rickets (XLH) due to elevated serum fibroblast growth factor 23 (FGF23) levels. We report a peculiar finding of markedly elevated serum 1,25(OH)2D levels in a patient with XLH complicated by autosomal dominant polycystic kidney disease (ADPKD) and retinitis pigmentosa (RP). She was diagnosed with XLH, ADPKD and RP at the age of 5, 13 and 15 years, respectively. After the diagnosis of ADPKD, the 1,25(OH)2D levels increased up to 282 pg/mL treated with a pharmacological dose of 1αOHD3 (1αOHD3). At the age of 17 years, under a physiological dose, serum 25-hydroxyvitamin D3 (25OHD3) and 1,25(OH)2D levels were 14.0 ng/mL and 93 pg/mL, respectively. With off-therapy for 3 days, the latter decreased to 9 pg/mL with an increased ratio of 24,25-dihydroxyvitamin D3 (24,25(OH)2D3)/25OHD3. Serum FGF23 and circulating soluble α-klotho (sKlotho) levels were 552 and 873 pg/mL, respectively, with the latter being almost half of the normal control. Since the coexistence of elevated serum FGF23 and 1,25(OH)2D levels contradicted the conventional FGF23 actions, we speculated on the possible association of decreased sKlotho with the peculiar vitamin D metabolism, although mechanisms in detail remained unknown.

Entities:  

Keywords:  24,25-Dihydroxyvitamin D3; Autosomal dominant polycystic kidney disease; Fibroblast growth factor 23; Hypophosphatemia; Retinitis pigmentosa; Soluble α-klotho

Year:  2016        PMID: 28509123      PMCID: PMC5438803          DOI: 10.1007/s13730-016-0238-x

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  13 in total

1.  Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule.

Authors:  Ming Chang Hu; Mingjun Shi; Jianning Zhang; Johanne Pastor; Teruyo Nakatani; Beate Lanske; M Shawkat Razzaque; Kevin P Rosenblatt; Michel G Baum; Makoto Kuro-o; Orson W Moe
Journal:  FASEB J       Date:  2010-05-13       Impact factor: 5.191

2.  Effects of the administration of phosphate on nuclear 1,25-dihydroxyvitamin D3 uptake by duodenal mucosal cells of Hyp mice.

Authors:  T Yamamoto; Y Seino; H Tanaka; K Yamaoka; H Kurose; M Ishida; H Yabuuchi
Journal:  Endocrinology       Date:  1988-02       Impact factor: 4.736

3.  A truncated polycystin-2 protein causes polycystic kidney disease and retinal degeneration in transgenic rats.

Authors:  Anna Rachel Gallagher; Sigrid Hoffmann; Nelson Brown; Anna Cedzich; Sujatha Meruvu; Dirk Podlich; Yuxi Feng; Vera Könecke; Uwe de Vries; Hans-Peter Hammes; Norbert Gretz; Ralph Witzgall
Journal:  J Am Soc Nephrol       Date:  2006-08-30       Impact factor: 10.121

4.  Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia.

Authors:  Thomas O Carpenter; Erik A Imel; Mary D Ruppe; Thomas J Weber; Mark A Klausner; Margaret M Wooddell; Tetsuyoshi Kawakami; Takahiro Ito; Xiaoping Zhang; Jeffrey Humphrey; Karl L Insogna; Munro Peacock
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

5.  Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status.

Authors:  Thomas O Carpenter; Karl L Insogna; Jane H Zhang; Bruce Ellis; Sherril Nieman; Christine Simpson; Elizabeth Olear; Caren M Gundberg
Journal:  J Clin Endocrinol Metab       Date:  2010-08-04       Impact factor: 5.958

6.  Does retinitis pigmentosa relate with polycystic kidney disease?

Authors:  Ismail Koçyigit; Aydin Unal; Ersin Ozaslan; Oktay Oymak; Cengiz Utas
Journal:  Int Urol Nephrol       Date:  2010-01-29       Impact factor: 2.370

7.  Soluble klotho and autosomal dominant polycystic kidney disease.

Authors:  Ivana Pavik; Philippe Jaeger; Lena Ebner; Diane Poster; Fabienne Krauer; Andreas D Kistler; Katharina Rentsch; Gustav Andreisek; Carsten A Wagner; Olivier Devuyst; Rudolf P Wüthrich; Christoph Schmid; Andreas L Serra
Journal:  Clin J Am Soc Nephrol       Date:  2011-12-22       Impact factor: 8.237

Review 8.  Molecular basis of Klotho: from gene to function in aging.

Authors:  Yuechi Xu; Zhongjie Sun
Journal:  Endocr Rev       Date:  2015-02-19       Impact factor: 19.871

9.  Determination of 25-hydroxyvitamin D in human plasma using high-performance liquid chromatography--tandem mass spectrometry.

Authors:  Naoko Tsugawa; Yoshitomo Suhara; Maya Kamao; Toshio Okano
Journal:  Anal Chem       Date:  2005-05-01       Impact factor: 6.986

10.  Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphate.

Authors:  Ivana Pavik; Philippe Jaeger; Andreas D Kistler; Diane Poster; Fabienne Krauer; Claudia Cavelti-Weder; Katharina M Rentsch; Rudolf P Wüthrich; Andreas L Serra
Journal:  Kidney Int       Date:  2010-10-13       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.